The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
Objective: Recent studies have reported conflicting results on the correlation between metformin use and outcomes in patients with colorectal cancer (CRC). A meta-analysis was performed to evaluate the efficacy of metformin therapy on the prognosis of CRC patients with type 2 diabetes mellitus (T2DM...
Enregistré dans:
Auteurs principaux: | Shan Tian, Hong-Bo Lei, Yu-Lan Liu, Yan Chen, Wei-Guo Dong |
---|---|
Format: | article |
Langue: | EN |
Publié: |
KeAi Communications Co., Ltd.
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c9c77016dbd541e48ce403e67cc79aae |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
par: Xiaogang Li, et autres
Publié: (2017) -
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014) -
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
par: Zhang Q, et autres
Publié: (2020) -
The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
par: Manal Mohammed Hashem, et autres
Publié: (2021) -
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
par: Lev Mikhaylovich Bershteyn, et autres
Publié: (2014)